Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.

Srivastava PK, Claggett BL, Solomon SD, McMurray JJV, Packer M, Zile MR, Desai AS, Rouleau JL, Swedberg K, Fonarow GC

Open source

DOI
10.1001/jamacardio.2018.3957
Published
2018 Dec 1
Container
JAMA cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamacardio.2018.3957,
  title = {Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.},
  author = {Srivastava PK and Claggett BL and Solomon SD and McMurray JJV and Packer M and Zile MR and Desai AS and Rouleau JL and Swedberg K and Fonarow GC},
  year = {2018},
  journal = {JAMA cardiology},
  doi = {10.1001/jamacardio.2018.3957},
  url = {https://doi.org/10.1001/jamacardio.2018.3957}
}

RIS

TY  - JOUR
TI  - Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
AU  - Srivastava PK
AU  - Claggett BL
AU  - Solomon SD
AU  - McMurray JJV
AU  - Packer M
AU  - Zile MR
AU  - Desai AS
AU  - Rouleau JL
AU  - Swedberg K
AU  - Fonarow GC
PY  - 2018
JO  - JAMA cardiology
DO  - 10.1001/jamacardio.2018.3957
UR  - https://doi.org/10.1001/jamacardio.2018.3957
ER  - 

APA

PK, S., BL, C., SD, S., JJV, M., M, P., MR, Z., AS, D., JL, R., K, S., & GC, F. (2018). Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2018.3957

Source records